
Tenax Therapeutics Inc (TENX)
NASDAQ
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -53.203 | -121.784 | -85.21 | -34.954 | -115.995 | -235.139 | -102.2 | -32.485 |
Return on Equity (%) | -67.94 | -136.968 | -108.01 | -36.64 | -119.731 | -385.082 | -160.797 | -35.172 |
Return on Invested Capital (%) | -126.874 | -73.225 | -110.195 | -524.283 | -1544.867 | -386.469 | -171.9 | -38.953 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 6.29 | 1.771 | 0.556 | 3.95 | 0.168 | 0.05 | 0.339 | 26.906 |
Earnings Per Share | -6.261 | -2.128 | -1.238 | -0.778 | -1.286 | -0.368 | -0.323 | -5.148 |
Cash Per Share | 1.137 | 1.861 | 0.723 | N/A | 0.221 | 0.071 | 0.41 | 27.742 |
Working Capital Per Share | 4.996 | 1.769 | 0.538 | N/A | 0.163 | 0.045 | 0.339 | 26.906 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -6.261 | -1.025 | -1.238 | -0.778 | -1.286 | -0.368 | -0.323 | -5.148 |
EBITDA Per Share | -6.261 | -1.025 | -1.238 | -0.778 | -1.286 | -0.368 | -0.323 | -5.148 |
Free Cash Flow Per Share | -6.267 | -2.128 | -1.238 | -0.778 | -1.286 | -0.368 | -0.323 | -5.148 |
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 1,41M | 3,79M | 6,74M | 12,62M | 25,21M | N/A | N/A | N/A |
Fin d'année 31 Décembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 20,41M |
Ratio cours/bénéfice | -1,15 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,21 |
Ratio prix/valeur comptable | 0,22 |
Rendement de dividende | - |
Actions en circulation | 3,97M |
Volume moyen (1 semaine) | 11,48k |
Volume moyen (1 mois) | 16,44k |
Variation sur 52 semaines | 44,07% |
Plus haut sur 52 semaines | 7,89 |
Plus bas sur 52 semaines | 2,77 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales